FICB for Hip Fracture Pain in Elderly

NCT ID
NCT07762846
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
RenJi Hospital
Conditions
Elderly, Fascia Iliaca Block, Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Postoperative Pain, QoR-15, Recovery of Function (G11.427.698.620)

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: The Early Intervention of Fascia Iliaca Compartment Block (FICB) as Pain Management for Elderly Patients With Hip Fracture to Improve Postoperative Rehabilitation: A Prospective Randomized Controlled Study

Enrollment: 144 participants (Estimated).

What is being studied

  • Procedure: Ultrasound-Guided Fascia Iliaca Compartment Block

Who may be eligible

Ages
65 Years to no maximum
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Age ≥ 65 years * Diagnosis of unilateral hip fracture (including femoral neck fracture or intertrochanteric fracture) confirmed by any imaging modality (X-ray, CT, or MRI) * Scheduled for hip fracture surgery under general anesthesia with endotracheal intubation (including total hip arthroplasty, hemiarthroplasty, intertrochanteric intramedullary nail fixation, closed reduction and internal fixation, etc.) * American Society of Anesthesiologists (ASA) physical status classification I-III * Able to provide written informed consent personally or via a legally authorized representative * Able to communicate normally in Chinese Exclusion Criteria: * Known allergy to ropivacaine, bupivacaine, or liposomal bupivacaine * Presence of any contraindication to nerve block, including but not limited to: nerve injury, coagulopathy, severe infection at the injection site, exudate at the injection site, etc. * Pre-existing psychiatric or neurological disorders, including but not limited to: depression, severe central nervous system depression, Parkinson's disease, basal ganglia lesions, schizophrenia, epilepsy, Alzheimer's disease, myasthenia gravis * Pre-existing severe cardiac, pulmonary, hepatic, or renal dysfunction, including but not limited to: history of heart failure, requiring dialysis, etc. * Inability to communicate preoperatively (e.g., coma, dementia) * Preoperative pain score \< 4 on Visual Analog Scale (VAS) or chronic/old hip fracture * Currently participating in another interventional clinical trial * Any other condition that, in the opinion of the investigator, would preclude evaluation of the therapeutic response or make it unlikely that the patient will complete the expected treatment course and follow-up

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: China

Sample of listed locations

  • Renji Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai, China — Site recruitment status not specified in the registry data

Study details

Start date
August 1, 2026
Primary completion date
December 1, 2027
Completion date
December 1, 2027
First posted
August 13, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07762846
Registry last updated
August 13, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07762846 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Neck Pain studies | Clinical trial FAQ